Maravai Lifesciences Holdings (MRVI) Cash from Investing Activities (QoQ) (2020 - 2026)
Maravai Lifesciences Holdings (MRVI) Cash from Investing Activities (QoQ) (2020 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 762,369.55 Bn | 762,369.51 Bn | - |
| 2 | Belite Bio | 55,096.00 Bn | 55,096.00 Bn | - |
| 3 | Quantum Biopharma | 17,755.80 Bn | 17,755.79 Bn | - |
| 4 | Legend Biotech | 3,486.00 Bn | 3,485.71 Bn | 242.10 Mn |
| 5 | Akari Therapeutics | 1,737.42 Bn | 1,737.41 Bn | - |
| 6 | Evaxion A | 1,551.28 Bn | 1,551.26 Bn | - |
| 7 | Psyence Biomedical | 227.32 Bn | 227.31 Bn | - |
| 8 | Vertex Pharmaceuticals | 110.84 Bn | 103.59 Bn | 2.59 Bn |
| 9 | Abivax | 91.71 Bn | 91.71 Bn | - |
| 10 | Maravai Lifesciences Holdings | 743.11 Mn | 734.71 Mn | 33.70 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -109.89% |
| Dec 31, 2025 | 27.75% |
| Sep 30, 2025 | 9.58% |
| Jun 30, 2025 | 86.01% |
| Mar 31, 2025 | -369.05% |
| Dec 31, 2024 | 44.96% |
| Sep 30, 2024 | -44.92% |
| Jun 30, 2024 | -45.66% |
| Mar 31, 2024 | 67.11% |
| Dec 31, 2023 | 16.86% |
| Sep 30, 2023 | 35.75% |
| Jun 30, 2023 | 65.36% |
| Mar 31, 2023 | -276.51% |
| Dec 31, 2022 | -216.74% |
| Sep 30, 2022 | -252.02% |
| Jun 30, 2022 | 99.31% |
| Mar 31, 2022 | -4,171.29% |
| Dec 31, 2021 | -104.77% |
| Sep 30, 2021 | 2,716.99% |
| Jun 30, 2021 | -62.82% |